FindMyKOL
Clinical trialNCT04211194CompletedObservational

Registry for Upper Gastrointestinal Bleeding

NCT04211194 is an observational study sponsored by AdventHealth. As of 21 Nov 2026, it is completed. It studies Peptic Ulcer Hemorrhage and Peptic Ulcer, Acute With Hemorrhage. The registry lists an enrollment of 2,999 participants at 1 site in 1 country. The registry lists a start date of 1 Oct 2019 and a primary completion date of 31 Jan 2021.

SponsorAdventHealth →Enrollment2,999Peptic Ulcer HemorrhagePeptic Ulcer, Acute With Hemorrhage
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT04211194
FieldValue
Registry IDNCT04211194
StatusCompleted
Study typeObservational study
Lead sponsorAdventHealth
Enrollment2,999
Registered sites1
Countries1
ConditionsPeptic Ulcer Hemorrhage and Peptic Ulcer, Acute With Hemorrhage
Start1 Oct 2019
Primary completion31 Jan 2021
Study completion31 Jan 2021
Last update posted17 Feb 2022

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This project aims to evaluate the data on all patients undergoing endoscopic therapy for upper gastrointestinal bleeding.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Florida, United States1 site
  • Center for Interventional Endoscopy

    Orlando

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFlorida: 1 siteFL1District of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT04211194

Each answer restates registry values shown on this page.

What is NCT04211194?

NCT04211194 is an observational study sponsored by AdventHealth. It studies Peptic Ulcer Hemorrhage and Peptic Ulcer, Acute With Hemorrhage.

Who leads NCT04211194?

The registry names Shyam Varadarajulu, MD (principal investigator, AdventHealth Orlando) as the overall official.

Where does NCT04211194 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When did NCT04211194 end?

The registry lists a primary completion date of 31 Jan 2021 and a study completion date of 31 Jan 2021. The sponsor last updated the record on 17 Feb 2022.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.